Literature DB >> 14995985

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family.

C Y Vossen1, S J Hasstedt, F R Rosendaal, P W Callas, K A Bauer, G J Broze, H Hoogendoorn, G L Long, B T Scott, E G Bovill.   

Abstract

BACKGROUND: Earlier studies found strong support for a genetic basis for regulation of coagulation factor levels and measures of a prethrombotic state (d-dimer, prothrombin fragment 1.2).
OBJECTIVES: Estimation of how much of the variation in the levels of coagulation factors and measures of a prethrombotic state, including measures of protein C activation and inactivation, could be attributed to heritability and household effect. PATIENTS AND METHODS: Blood samples were collected from 330 members of a large kindred of French-Canadian origin with type I protein C deficiency. Heritability and common household effect were estimated for plasma concentrations of prothrombin, factor (F)V, factor VIII, factor (F)IX, fibrinogen, von Willebrand factor (VWF), antithrombin, protein C, protein S, protein Z, protein Z-dependent protease inhibitor (ZPI), fibrinopeptide A (FPA), protein C activation peptide (PCP), activated protein C-protein C inhibitor complex (APC-PCI), activated protein C-alpha1-antitrypsin complex (APC-alpha1AT), prothrombin fragment 1.2 (F1.2) and d-dimer, using the variance component method in sequential oligo-genic linkage analysis routines (SOLAR).
RESULTS: The highest heritability was found for measures of thrombin activity (PCP and FPA). High estimates were also found for prothrombin, FV, FIX, protein C, protein Z, ZPI, APC-PCI and APC-alpha1AT. An important influence of shared household effect on phenotypic variation was found for VWF, antithrombin, protein S and F1.2.
CONCLUSIONS: We found strong evidence for the heritability of single coagulation factors and measures of a prethrombotic state. Hemostatic markers with statistically significant heritability constitute potential targets for the identification of novel genes involved in the control of quantitative trait loci.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14995985     DOI: 10.1111/j.1538-7933.2003.00592.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  20 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

Review 2.  Introduction to haemostasis from a pharmacodynamic perspective.

Authors:  Cornelis Kluft; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

3.  Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus.

Authors:  F Yesim K Demirci; Amy S Dressen; Candace M Kammerer; M Michael Barmada; Amy H Kao; Rosalind Ramsey-Goldman; Susan Manzi; M Ilyas Kamboh
Journal:  J Rheumatol       Date:  2011-01-15       Impact factor: 4.666

4.  Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS.

Authors:  Kiyoko Kaneko; Tomoyo Yamanobe; Maki Onoda; Ken-ichi Mawatari; Kazuya Nakagomi; Shin Fujimori
Journal:  Urol Res       Date:  2005-08-25

5.  Genetic variants associated with protein C levels.

Authors:  C Y Vossen; B P Koeleman; S J Hasstedt; I J Nijman; I J Renkens; P W Callas; F R Rosendaal; E G Bovill
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

Review 6.  Current controversies in the diagnosis and management of von Willebrand disease.

Authors:  Anne T Neff
Journal:  Ther Adv Hematol       Date:  2015-08

7.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

8.  Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.

Authors:  Jing Zhang; Yizheng Tu; Lan Lu; Nina Lasky; George J Broze
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

9.  Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.

Authors:  Jordan A Shavit; Ani Manichaikul; Heidi L Lemmerhirt; Karl W Broman; David Ginsburg
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

10.  PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study.

Authors:  A P Reiner; C L Carty; N S Jenny; C Nievergelt; M Cushman; D J Stearns-Kurosawa; S Kurosawa; L H Kuller; L A Lange
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.